Trials / Completed
CompletedNCT00414752
Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking
A Randomized, Double Blind, Multiple Dose, Cross-Over, Placebo- and Active-Controlled Proof of Concept Study to Explore the Effects of AFQ056 and Nicotine (Active Comparator) on Craving and Withdrawal During Voluntary Smoking Abstinence in Healthy Smokers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety and efficacy of AFQ056 and nicotine compared to placebo on craving and withdrawal symptoms during voluntary smoking stoppage in healthy smokers. This study will also assess how the body interacts with AFQ056.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AFQ065 |
Timeline
- Start date
- 2006-09-01
- First posted
- 2006-12-22
- Last updated
- 2007-06-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00414752. Inclusion in this directory is not an endorsement.